Search Results - Endovascular Today

evt | Article | February 2026

Addressing Pelvic Venous Disease With a New Class of Coils

Improving recognition and outcomes in pelvic venous disease through embolization, with case examples.

With Gloria Salazar, MD, FSIR; Ronald Winokur, MD, FSIR, RPVI; Marissa Famularo, DO; Eric Hager, MD; Driss Raissi, MD, MBA, FSIR; and Brian Do, DO

evt | Article | July 2022

The Need for Comprehensive Venous Care

Outlining factors contributing to fragmented venous care.

By Erin H. Murphy, MD, FACS

evt | Article | June 2025

Middle Meningeal Artery Embolization in the Treatment of Chronic Headaches

Exploring middle meningeal artery embolization as a promising experimental therapy for chronic headaches, emphasizing the need for further clinical trials to validate efficacy, optimize patient selection and the technical approach, and ensure safety.

By Christopher H. Sollenberger, MS; Kyle Scott, MD; Aaron Anandarajah; Redi Rahmani, MD; Eric A. Kaiser, MD; Visish M. Srinivasan, MD; Jan Karl Burkhardt, MD, MBA; Seniha Ozudogru, MD; Bryan Pukenas, MD; and Joshua Catapano, MD

evt | Article | March 2020

Reversing the Miniaturization Trend: Why Going Bigger Is Better for Treating VTE

Design concept and case experiences—how the large-bore Triever24 catheter can extract large volumes of venous clot to optimize procedural success in different VTE settings.

With Christopher M. Huff, MD, FACC, RPVI; Michael A. Jolly, MD, FACC, RPVI; Mitchell J. Silver, DO, FACC, FSVM, RPVI; Venkat P. Tummala, MD; and Eric Trestman, MD

evt | Article | December 2014 Supplement

Clinical Perspectives on DAART

With Samir Germanwala, DO; Eric C. Scott, MD; and Mehdi Shishehbor, DO, MPH

evt | Article | October 2025

Year in Review: Top Papers in Interventional Oncology

Studies evaluating treatment for unresectable hepatocellular carcinoma and metastatic uveal melanoma are highlighted.

By Eric Wehrenberg-Klee, MD, and Suvranu Ganguli, MD, FSIR

evt | Article | July 2021

Panel Discussion: The Most Challenging Chronic Deep Venous Occlusions

Moderator: Gerard O’Sullivan, MD
Panelists: Mohammad E. Barbati, MD, FEBVS; Kush R. Desai, MD, FSIR; Houman Jalaie, MD; Erin H. Murphy, MD, FACS; and Emma Wilton, MD, FRCS

evt | News | January 17, 2025

R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for ELITE-BTK Pivotal Trial

January 17, 2025—R3 Vascular Inc. recently announced that it received WCG institutional review board (IRB) approval for the ELITE-BTK pivotal trial of its next-generation Magnitude drug-eluting bioresorbable scaffold for the treatment of below-the-knee peripheral arterial disease.